SEC CIK 1223756
CHASE ANTHONY R
Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| SRPTview stock → | 67,194 | 2015-02-27 |
| NESRview stock → | 17,800 | 2026-08-14 |
| NBRview stock → | 15,408 | 2026-06-02 |
| LYBview stock → | 13,603 | 2026-05-22 |
| PARRview stock → | 10,529 | 2023-10-05 |
| CFRview stock → | 1 | 2022-06-23 |
Position History — PARR
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PARR
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-10-05 | Grant / award (derivative) | 1,318 | $0.00 | 1,318 |
| 2024-07-05 | Grant / award (derivative) | 1,015 | $0.00 | 1,015 |
| 2024-04-05 | Grant / award (derivative) | 633 | $0.00 | 633 |
| 2024-01-05 | Grant / award (derivative) | 721 | $0.00 | 721 |
| 2023-10-05 | Option exercise (derivative) | 2,103 | $0.00 | 2,103 |
| 2023-10-05 | Grant / award (derivative) | 770 | $0.00 | 770 |
| 2023-10-05 | J | 2,103 | $0.00 | 10,529 |
| 2023-07-05 | Grant / award (derivative) | 923 | $0.00 | 923 |
| 2023-07-05 | Option exercise (derivative) | 2,630 | $0.00 | 2,630 |
| 2023-07-05 | J | 2,630 | $0.00 | 8,426 |
| 2023-04-05 | Option exercise (derivative) | 3,030 | $0.00 | 3,030 |
| 2023-04-05 | Grant / award (derivative) | 881 | $0.00 | 881 |
| 2023-01-05 | Grant / award (derivative) | 1,132 | $0.00 | 1,132 |
| 2023-01-05 | Option exercise (derivative) | 1,335 | $0.00 | 1,335 |
| 2023-01-05 | J | 1,335 | $0.00 | 2,766 |
| 2023-01-05 | J | 3,030 | $0.00 | 5,796 |
| 2022-10-05 | Grant / award (derivative) | 2,103 | $0.00 | 2,103 |
| 2022-07-05 | Grant / award (derivative) | 2,630 | $0.00 | 2,630 |
| 2022-04-05 | Grant / award (derivative) | 3,030 | $0.00 | 3,030 |
| 2022-01-05 | Grant / award (derivative) | 1,335 | $0.00 | 1,335 |
| 2021-10-05 | Grant / award | 1,431 | $0.00 | 1,431 |
| 2021-07-29 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.